Appropriate statistical methods to compare dose responses of methionine sources.

Two sources of methionine (Met) activity are frequently used in commercial feed formulation: DL-2-hydroxy-4-(methylthio) butanoic acid (HMTBA), most commonly available as an 88% solution with 12% water; and DL-methionine (DLM, 99% powder). Despite the fact that both compounds have been in commercial use for over 50 yr, controversy and confusion remain with respect to their relative bioefficacy (RBE). This paper presents a review of the use of a nonlinear common plateau asymptotic regression technique (NLCPAR) that has been used to compare the 2 Met sources with particular emphasis on the validity of the basic assumptions of that model. The thesis of this paper is that the controversy is due, at least in part, to the misapplication of this regression technique to estimate the RBE of HMTBA and DLM. The NLCPAR model is a bioassay with the key dependent assumptions that HMTBA is a dilution of DLM, and that each follows dose-response curves of the same form and approach a common plateau. Because both provide Met activity, it may be considered reasonable to accept these assumptions; however, specifically testing them demonstrated that the assumption of a common dose-response is not supported by data. The common plateau assumption was tested with an alternative approach of fitting nonlinear separate plateaus asymptotic regression (NLSPAR) to a set of 13 published broiler studies in which the NLCPAR model had been used to estimate RBE of HMTBA and DLM. The hypothesis of a common plateau was rejected (P < 0.01), meaning that the conclusion that HMTBA had lower bioefficacy than DLM based on the NLCPAR methodology was not valid. An example using published data demonstrated that the NLSPAR model was a significantly better fit than the NLCPAR model, and showed that HMTBA and DLM followed different dose responses. Consequently, there was no single value for RBE for the entire dose range; rather, the RBE of the 2 compounds varied with use level. The evidence presented here indicates that separate plateau models should be used when comparing these 2 products. These more valid models can then be used for predictions of differences between HMTBA and DLM at levels of expected use.

A multiple regression model approach to contrast the performance of 2-hydroxy-4-methylthio butanoic acid and DL-methionine supplementation tested in broiler experiments and reported in the literature.

The purpose of this paper was to compile all available literature comparing the relative performance of 2-hydroxy-4-methylthio butanoic acid (HMTBA) with DL-methionine (DLM) in broiler chickens and using multiple regression techniques, to estimate the predicted dose responses and relative performance of the 2 Met compounds for gain and feed conversion (FC). A database was developed that contained all available broiler studies in which HMTBA and DLM were both present in the same study; weight gain was recorded; Met addition, age of birds, and duration of study were defined; and an unsupplemented control treatment was present. Sixty-two references complied with these criteria and included 100 experiments with 427 observations for HMTBA and 411 for DLM. Multiple regression analysis of the database was used to identify the experimental and dietary conditions that contributed to the gain and FC responses of each source of Met activity. All identified variables contributed similarly to each Met source prediction model and both gain and FC models described a quadratic dose response. Under the average conditions of the database, the predicted responses for gain and FC models did not significantly differ between HMTBA and DLM. However, a trend was observed (P < or = 0.1) for the peak gain response for HMTBA to be numerically greater than DLM, suggesting benefits of HMTBA over DLM in the region of supplementation that is commercially relevant. The experimental and nutritional conditions that contribute to the response to HTMBA and DLM were identified and are discussed in the paper. This statistical approach provided a means to summarize the results obtained from a multitude of studies conducted over the last 5 decades and has provided a meaningful estimate of the relative performance of the 2 sources of Met activity. The lack of differences between the 2 predicted models under experimental and commercial conditions supports an overall conclusion of equal performance of DLM and HTMBA when compared on an equal molar basis.

Efficacy of Linco-Spectin medication on mycoplasma meleagridis airsacculitis in turkey poults.

The efficacy of Linco-Spectin (LS) water medication was determined against Mycoplasma meleagridis (MM) airsacculitis in turkey poults under controlled conditions. The poults were obtained from commercial flocks naturally infected with MM. Water medication was given for the first five days of life. In Georgia and Ohio, LS was given at 0, 1, 2, and 4 g per gallon of drinking water. In California and Minnesota, LS was administered at 0 and 2 g per gallon of drinking water. At three weeks old, the birds were weighed individually and examined serologically, culturally, and grossly for MM airsacculitis. LS at 2 g activity per gallon of drinking water was beneficial in controlling MM airsacculitis in all four trials.